Reader to Reader: Sept. 4
London Free Press
15, the London and District Multiple Myeloma Support Group held its second annual Dorchester Walk of Champions for myeloma research. ...

Beacon NewsFlashes – September 3, 2010
The Myeloma Beacon
Revlimid is approved in the US for the treatment of multiple myeloma as well as a collection of blood disorders called myelodysplastic syndromes. ...
Celgene Officially Notified of ANDA Filing for REVLIMID(R)Trading Markets (press release)
Beacon NewsFlashes – September 3, 2010The MDS Beacon

all 31 news articles »

TheMedGuru
Lisa Ray Talks On Struggle Against Cancer
Bollywood Non-Stop
The actress has taken multiple myeloma on 23 June 2009 and started her first cycle of treatment for cancer on 2 July 2009. Lisa Ray has announced on April ...
Lisa Ray - Fighting against CancerBreakingNewsOnline.
Lisa Ray talks about breast cancer!FitnHit.com (blog)
After cancer battle, Lisa Ray spreads hopeDaily News & Analysis
MSN India
all 21 news articles »

GBI Research's report analyzes licensing agreement to shape global market
News-Medical.net
GBI Research's report, "Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and ...

A Look at Immunogen Beyond the T-DM1 Setback
Seeking Alpha (blog)
The second trial is a phase I in multiple myeloma that will probably be reported at ASH in December. I reviewed earlier results from this trial here. ...

and more »

Guide To Nutrition In Multiple Myeloma – Part 2: Supplements
The Myeloma Beacon
This article is the second in a two-part series about nutrition for multiple myeloma patients. The first article provides an introduction to nutrition for ...
Pat's Place: A Patient's Reflections On The Progress Of Multiple Myeloma ResearchThe Myeloma Beacon

all 2 news articles »

Bone morphogenetic protein-2 higher in patients with multiple myeloma
HemOncToday
Results from a recent study showed that bone morphogenetic protein-2 was a mediator for hepcidin-stimulatory capacity in multiple myeloma sera, ...

NICE backs Thalidomide and Velcade for multiple myeloma
Pharma Times
Celgene's Thalidomide and Janssen-Cilag's Velcade have been recommended as options to treat patients with multiple myeloma on the National Health Service by ...